Skip to main content

Breadcrumb

  1. Home

Regulatory and Accreditation Programs

Valid for Measure Submission
Valid for Initial Endorsement
Valid for Maintenance

Pediatric Asthma Emergency Department Use

  • This measure estimates the rate of emergency department visits for children ages 3 – 21 who are being managed for identifiable asthma, using specified definitions. The measure is reported in visits per 100 child-years.

    CBE ID
    3599

Persistence of Beta-Blocker Treatment After a Heart Attack

  • The percentage of patient’s 18 years of age and older during the measurement year who were hospitalized and discharged from July 1 of the year prior to the measurement year to June 30 of the measurement year with a diagnosis of acute myocardial infarction (AMI) and who received persistent beta-blocker treatment for six months after discharge.

    CBE ID
    0071

Pharmacotherapy Management of COPD Exacerbation

  • This measure assesses the percentage of COPD exacerbations for patients 40 years of age and older who had an acute inpatient discharge or ED visit on or between January 1-November 30 of the measurement year and who were dispensed appropriate medications. Two rates are reported:
    1. Dispensed a systemic corticosteroid (or there was evidence of an active prescription) within 14 days of the event.
    2. Dispensed a bronchodilator (or there was evidence of an active prescription) within 30 days of the event.

    CBE ID
    2856

PointRight® Pro Long Stay(TM) Hospitalization Measure

  • The PointRight Pro Long Stay Hospitalization Measure is an MDS-based, risk-adjusted measure of the rate of hospitalization of long-stay patients (also known as “residents”) of skilled nursing facilities (SNFs) averaged across the year, weighted by the number of stays in each quarter.

    CBE ID
    2827

Potentially Harmful Drug-Disease Interactions in the Elderly

  • The percentage of patients 65 years of age and older who have evidence of an underlying disease, condition or health concern and who are dispensed an ambulatory prescription for a potentially harmful medication, concurrent with or after the diagnosis. Three rates are reported for this measure:
    -Rate 1: The percentage of those with a history of falls that received a potentially harmful medication
    -Rate 2: The percentage of those with dementia that received a potentially harmful medication

    CBE ID
    2993

Pressure ulcer prevalence (hospital acquired)

  • The total number of patients that have hospital-acquired (nosocomial) category/stage II or greater pressure ulcers on the day of the prevalence measurement episode.

    CBE ID
    0201